85 research outputs found
Investigation of the Role of TNF-Ξ± Converting Enzyme (TACE) in the Inhibition of Cell Surface and Soluble TNF-Ξ± Production by Acute Ethanol Exposure
Toll-like receptors (TLRs) play a fundamental role in the immune system by detecting pathogen associated molecular patterns (PAMPs) to sense host infection. Ethanol at doses relevant for humans inhibits the pathogen induced cytokine response mediated through TLRs. The current study was designed to investigate the mechanisms of this effect by determining whether ethanol inhibits TLR3 and TLR4 mediated TNF-Ξ± secretion through inhibition of transcription factor activation or post-transcriptional effects. In NF-ΞΊB reporter mice, activation of NF-ΞΊB in vivo by LPS was inhibited by ethanol (LPS alone yielded 170,000Β±35,300 arbitrary units of light emission; LPS plus ethanol yielded 56,120Β±16880, pβ=β0.04). Inhibition of protein synthesis by cycloheximide revealed that poly I:C- or LPS-induced secreted TNF-Ξ± is synthesized de novo, not released from cellular stores. Using real time RT-PCR, we found inhibition of LPS and poly I:C induced TNF-Ξ± gene transcription by ethanol. Using an inhibitor of tumor necrosis factor alpha converting enzyme (TACE), we found that shedding caused by TACE is a prerequisite for TNF-Ξ± release after pathogen challenge. Flow cytometry was used to investigate if ethanol decreases TNF-Ξ± secretion by inhibition of TACE. In cells treated with LPS, ethanol decreased both TNF-Ξ± cell surface expression and secretion. For example, 4.69Β±0.60% of untreated cells were positive for cell surface TNF-Ξ±, LPS increased this to 25.18Β±0.85%, which was inhibited by ethanol (86.8 mM) to 14.29Β±0.39% and increased by a TACE inhibitor to 57.88Β±0.62%. In contrast, cells treated with poly I:C had decreased secretion of TNF-Ξ± but not cell surface expression. There was some evidence for inhibition of TACE by ethanol in the case of LPS, but decreased TNF-Ξ± gene expression seems to be the major mechanism of ethanol action in this system
Deletion of Nlrp3 protects from inflammation-induced skeletal muscle atrophy
BACKGROUND: Critically ill patients develop atrophic muscle failure, which increases morbidity and mortality. Interleukin-1Ξ² (IL-1Ξ²) is activated early in sepsis. Whether IL-1Ξ² acts directly on muscle cells and whether its inhibition prevents atrophy is unknown. We aimed to investigate if IL-1Ξ² activation via the Nlrp3 inflammasome is involved in inflammation-induced atrophy. METHODS: We performed an experimental study and prospective animal trial. The effect of IL-1Ξ² on differentiated C2C12 muscle cells was investigated by analyzing gene-and-protein expression, and atrophy response. Polymicrobial sepsis was induced by cecum ligation and puncture surgery in Nlrp3 knockout and wild type mice. Skeletal muscle morphology, gene and protein expression, and atrophy markers were used to analyze the atrophy response. Immunostaining and reporter-gene assays showed that IL-1Ξ² signaling is contained and active in myocytes. RESULTS: Immunostaining and reporter gene assays showed that IL-1Ξ² signaling is contained and active in myocytes. IL-1Ξ² increased Il6 and atrogene gene expression resulting in myocyte atrophy. Nlrp3 knockout mice showed reduced IL-1Ξ² serum levels in sepsis. As determined by muscle morphology, organ weights, gene expression, and protein content, muscle atrophy was attenuated in septic Nlrp3 knockout mice, compared to septic wild-type mice 96Β h after surgery. CONCLUSIONS:
IL-1Ξ² directly acts on myocytes to cause atrophy in sepsis. Inhibition of IL-1Ξ² activation by targeting Nlrp3 could be useful to prevent inflammation-induced muscle failure in critically ill patients
Overexpression of IL-1ra gene up-regulates interleukin-1Ξ² converting enzyme (ICE) gene expression: possible mechanism underlying IL-1Ξ²-resistance of cancer cells
We investigated the interaction of endogenous interleukin (IL)-1Ξ², IL-1ra, and interleukin-1Ξ² converting enzyme (ICE) in four human urological cancer cell lines, KU-19-19, KU-1, KU-2 and KU-19-20. Northern blot analysis showed that IL-1Ξ² gene was expressed in all cell lines. On the other hand, in KU-19-19 and KU-19-20, the gene expressions of both IL-1ra and ICE were suppressed. MTT assay revealed that IL-1Ξ² (10 ng mlβ1) promoted cell growth in KU-19-19 and KU-19-20, while it inhibited in KU-1 and KU-2. An ICE inhibitor, Acetyl-Tyr-Val-Ala-Asp-CHO (YVAD-CHO) blocked IL-1Ξ²-induced growth inhibition in KU-1 and KU-2. Overexpression of the secretory type IL-1ra with adenovirus vector (AxIL-1ra) enhanced ICE gene expression, while exogenous IL-1ra (100 ng mlβ1) did not enhance it. Furthermore, AxIL-1ra treatment promoted endogenous IL-1Ξ² secretion and induced significant growth inhibition and apoptotic cell death on KU-19-19 and KU-19-20. Treatment with either IL-1ra (100 ng mlβ1), IL-1Ξ² antibody (100 ΞΌg mlβ1), or YVAD-CHO blocked AxIL-1ra-induced cell death in KU-19-19 and KU-19-20. These results suggest that IL-1Ξ²-sensitivity depends on the level of ICE gene expression, which is regulated by the level of endogenous sIL-1ra expression. This is a first report on the intracellular function of sIL-1ra and these findings may provide key insights into the mechanism underlying the viability of cancer cells. Β© 1999 Cancer Research Campaig
Monocyte Derived Microvesicles Deliver a Cell Death Message via Encapsulated Caspase-1
Apoptosis depends upon the activation of intracellular caspases which are classically induced by either an intrinsic (mitochondrial based) or extrinsic (cytokine) pathway. However, in the process of explaining how endotoxin activated monocytes are able to induce apoptosis of vascular smooth muscle cells when co-cultured, we uncovered a transcellular apoptosis inducing pathway that utilizes caspase-1 containing microvesicles. Endotoxin stimulated monocytes induce the cell death of VSMCs but this activity is found in 100,000 g pellets of cell free supernatants of these monocytes. This activity is not a direct effect of endotoxin, and is inhibited by the caspase-1 inhibitor YVADcmk but not by inhibitors of Fas-L, IL-1Ξ² and IL-18. Importantly, the apoptosis inducing activity co-purifies with 100 nm sized microvesicles as determined by TEM of the pellets. These microvesicles contain caspase-1 and caspase-1 encapsulation is required since disruption of microvesicular integrity destroys the apoptotic activity but not the caspase-1 enzymatic activity. Thus, monocytes are capable of delivering a cell death message which depends upon the release of microvesicles containing functional caspase-1. This transcellular apoptosis induction pathway describes a novel pathway for inflammation induced programmed cell death
Genomic and gene expression profiling of minute alterations of chromosome arm 1p in small-cell lung carcinoma cells
Genetic alterations occurring on human chromosome arm 1p are common in many types of cancer including lung, breast, neuroblastoma, pheochromocytoma, and colorectal. The identification of tumour suppressors and oncogenes on this arm has been limited by the low resolution of current technologies for fine mapping. In order to identify genetic alterations on 1p in small-cell lung carcinoma, we developed a new resource for fine mapping segmental DNA copy number alterations. We have constructed an array of 642 ordered and fingerprint-verified bacterial artificial chromosome clones spanning the 120 megabase (Mb) 1p arm from 1p11.2 to p36.33. The 1p arm of 15 small-cell lung cancer cell lines was analysed at sub-Mb resolution using this arm-specific array. Among the genetic alterations identified, two regions of recurrent amplification emerged. They were detected in at least 45% of the samples: a 580βkb region at 1p34.2βp34.3 and a 270βkb region at 1p11.2. We further defined the potential importance of these genomic amplifications by analysing the RNA expression of the genes in these regions with Affymetrix oligonucleotide arrays and semiquantitative reverse transcriptaseβpolymerase chain reaction. Our data revealed overexpression of the genes HEYL, HPCAL4, BMP8, IPT, and RLF, coinciding with genomic amplification
P2 purinergic receptor modulation of cytokine production
Cytokines serve important functions in controlling host immunity. Cells involved in the synthesis of these polypeptide mediators have evolved highly regulated processes to ensure that production is carefully balanced. In inflammatory and immune disorders, however, mis-regulation of the production and/or activity of cytokines is recognized as a major contributor to the disease process, and therapeutics that target individual cytokines are providing very effective treatment options in the clinic. Leukocytes are the principle producers of a number of key cytokines, and these cells also express numerous members of the purinergic P2 receptor family. Studies in several cellular systems have provided evidence that P2 receptor modulation can affect cytokine production, and mechanistic features of this regulation have emerged. This review highlights three separate examples corresponding to (1) P2Y6 receptor mediated impact on interleukin (IL)-8 production, (2) P2Y11 receptor-mediated affects on IL-12/23 output, and (3) P2X7 receptor mediated IL-1Ξ² posttranslational processing. These examples demonstrate important roles of purinergic receptors in the modulation of cytokine production. Extension of these cellular observations to in vivo situations may lead to new therapeutic strategies for treating cytokine-mediated diseases
Human macrophage colony-stimulating factor is expressed at and shed from the cell surface
- β¦